Suppr超能文献

相似文献

1
Conformational variability of matrix metalloproteinases: beyond a single 3D structure.
Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5334-9. doi: 10.1073/pnas.0407106102. Epub 2005 Apr 4.
2
Crystal structure of the catalytic domain of human matrix metalloproteinase 10.
J Mol Biol. 2004 Feb 20;336(3):707-16. doi: 10.1016/j.jmb.2003.12.033.
4
Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor.
J Mol Biol. 2001 Sep 28;312(4):743-51. doi: 10.1006/jmbi.2001.4953.
6
Catalytic domain of MMP20 (Enamelysin) - the NMR structure of a new matrix metalloproteinase.
FEBS Lett. 2007 Oct 2;581(24):4723-6. doi: 10.1016/j.febslet.2007.08.069. Epub 2007 Sep 6.

引用本文的文献

1
In-silico study of rosmarinic acid roles in inhibiting breast cancer progression.
Biomedicine (Taipei). 2025 Mar 1;15(1):23-30. doi: 10.37796/2211-8039.1638. eCollection 2025.
4
Dermato-cosmeceutical properties of (Kunth) Dugand: Chemical profiling, and studies.
Saudi Pharm J. 2023 Oct;31(10):101778. doi: 10.1016/j.jsps.2023.101778. Epub 2023 Sep 1.
6
Developments in Carbohydrate-Based Metzincin Inhibitors.
Pharmaceuticals (Basel). 2020 Nov 10;13(11):376. doi: 10.3390/ph13110376.
7
Inhibitory Antibodies Designed for Matrix Metalloproteinase Modulation.
Molecules. 2019 Jun 18;24(12):2265. doi: 10.3390/molecules24122265.
9
Synthesis and in Vitro and in Vivo Evaluation of MMP-12 Selective Optical Probes.
Bioconjug Chem. 2016 Oct 19;27(10):2407-2417. doi: 10.1021/acs.bioconjchem.6b00377. Epub 2016 Sep 14.

本文引用的文献

1
Residual dipolar couplings in structure determination of biomolecules.
Chem Rev. 2004 Aug;104(8):3519-40. doi: 10.1021/cr030419i.
2
Crystal structure of the catalytic domain of human matrix metalloproteinase 10.
J Mol Biol. 2004 Feb 20;336(3):707-16. doi: 10.1016/j.jmb.2003.12.033.
3
Matrix metalloprotease inhibitors: design from structure.
Biochem Soc Trans. 2004 Feb;32(Pt 1):17-20. doi: 10.1042/bst0320017.
4
Similarity of binding sites of human matrix metalloproteinases.
J Biol Chem. 2004 Apr 2;279(14):14194-200. doi: 10.1074/jbc.M313474200. Epub 2004 Jan 19.
5
X-ray structures of binary and ternary enzyme-product-inhibitor complexes of matrix metalloproteinases.
Angew Chem Int Ed Engl. 2003 Jun 16;42(23):2673-6. doi: 10.1002/anie.200350957.
6
Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials.
Cancer Metastasis Rev. 2003 Jun-Sep;22(2-3):177-203. doi: 10.1023/a:1023047431869.
7
Impact of mobility on structure-based drug design for the MMPs.
J Am Chem Soc. 2002 Oct 30;124(43):12658-9. doi: 10.1021/ja027391x.
9
Matrix metalloproteinase inhibitors and cancer: trials and tribulations.
Science. 2002 Mar 29;295(5564):2387-92. doi: 10.1126/science.1067100.
10
Design and therapeutic application of matrix metalloproteinase inhibitors.
Chem Rev. 1999 Sep 8;99(9):2735-76. doi: 10.1021/cr9804543.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验